Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Bellis perennis*, commonly known as the English daisy, is a medicinal plant belonging to the Asteraceae family that is utilized both in traditional herbal medicine and homeopathy. In conventional pharmacological research, extracts of the plant have demonstrated antioxidant, antimicrobial, and insulin-mimetic activities, specifically through the induction of GLUT4 translocation to enhance glucose uptake in muscle and adipose tissues. In the homeopathic tradition, it is recognized for treating soft tissue trauma, deep-seated bruising, and postoperative recovery, particularly following abdominal or pelvic surgery. Clinical trials have investigated its efficacy in preventing seroma formation after mastectomy and reducing blood loss during the third stage of labor. Furthermore, in vitro studies suggest it has osteogenic potential by upregulating markers such as alkaline phosphatase and osteocalcin, potentially aiding in bone regeneration and fracture healing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bellis perennis.